Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

NCT06934967 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Interventions

DRUG: LNP023

Sponsor

Novartis Pharmaceuticals